Pharma highlights from 2019 and a look ahead to 2020Paul Tunnah looks at the trends that defined this year in pharma and what they might mean for Share XPharma highlights from 2019 and a look ahead to 2020https://pharmaphorum.com/views-analysis-patients/pharma-highlights-2019-look-ahead-2020/
A year of building patient centric foundationsIt’s been a year of putting patient centricity theory into practice, as companies and industry organisations alike have Share XA year of building patient centric foundationshttps://pharmaphorum.com/views-analysis-patients/2019-in-review-a-year-of-building-patient-centric-foundations/
Nine for 2019: how did we do on our predictions, and what does this mean for 2020?Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead. At Share XNine for 2019: how did we do on our predictions, and what does this mean for 2020?https://pharmaphorum.com/views-and-analysis/nine-for-2019-2020/
Nine for 2019: Opportunities for pharmaIn the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical Share XNine for 2019: Opportunities for pharmahttps://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/
Nine for 2019: Challenges impacting pharmaAs we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping Share XNine for 2019: Challenges impacting pharmahttps://pharmaphorum.com/r-d/views-analysis-r-d/nine-for-2019-challenges-impacting-pharma/
